Daniel Kemp is the founder of Shinobi Therapeutics. Shinobi Therapeutics has raised $119M in total funding. Latest round: Series A.
Dr. Dan Kemp serves as the CEO of Shinobi Therapeutics, bringing over two decades of leadership experience in biotech startups and large pharmaceutical companies. He specializes in cell and gene therapy platforms, having previously held roles such as CEO of Wugen and Vice President of Cell Therapies BD & Operations at Takeda. His experience includes negotiating and leading over $300M in startup investments and more than 20 transactions.
Full founder directory · Investor directory · Company funding database · Fundraising library